| Literature DB >> 29686512 |
Zhenna Fu1, Zhenzhen Wei2, Mingsan Miao2.
Abstract
To study the effect of raspberry total flavonoids on perimenopausal model in mice. Blank group, sham operation, and the rest of the mice made the menopausal model. Choose 72 mice castrated completely random divided into 6 groups for the experiment, respectively: model group, gengnianan (GNA) capsule group, soybean isoflavone soft (SIS) capsule group, high, mid and low dose group of total flavonoids of raspberry (TFR). Animals in each group were given the corresponding drugs tenth days after operation, and were given intragastrical administration of once a day for continuous administration of 21 days. Each group of mice in the administration of 18 days to determine the number of autonomic activities within 5 min, in the administration of 19-20 days to determine the incubation of the mice first entry into the darkroom and the number of shocks into the darkroom within 5 min. At 2 h after the last administration (fasting for 12 h), mice were sacrificed and serum was collected. Serum levels of E2, T, LH and FSH were measured. Dissect the uterus, uterus, thymus and spleen. Weigh the wet weight and calculate the organ index, the morphological changes of uterus, thymus and spleen were observed. The results showed that the TFR had a good therapeutic effect on the perimenopausal model of mice after giving a high, mid and low dose of raspberry flavonoids for some time.Entities:
Keywords: Autonomic activity; Memory; Perimenopausal model; Sex hormone levels; Total flavonoids of raspberry (TFR)
Year: 2017 PMID: 29686512 PMCID: PMC5910651 DOI: 10.1016/j.sjbs.2017.08.009
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Effect of autonomic activity on the perimenopausal period in mice ( ± s, n = 12).
| Group | Dose (mg/kg) | Number of activities (frequency) | Number of standing (frequency) |
|---|---|---|---|
| Blank group | – | 134.333 ± 18.102 | 59.583 ± 8.959 |
| Model group | – | 85.667 ± 11.555 | 27.333 ± 5.662 |
| GNA capsule group | 675 | 130.500 ± 19.870 | 52.083 ± 11.365 |
| SIS capsule group | 250 | 125.917 ± 11.547 | 50.167 ± 14.640 |
| TFR high-dose group | 200 | 123.083 ± 14.902 | 45.500 ± 10.068 |
| TFR mid-dose group | 100 | 134.583 ± 17.926 | 43.750 ± 8.159 |
| TFR low-dose group | 50 | 104.750 ± 12.263 | 36.667 ± 5.805 |
Note: Compared with the model group.
P < 0.05.
P < 0.01.
Effects of TFR on the incubation period and the number of shocks in the mice perimenopausal model ( ± s, n = 12).
| Group | Dose (mg/kg) | Icubation period (S) | Number of shocks (frequency) |
|---|---|---|---|
| Blank group | – | 191.000 ± 52.401 | 1.917 ± 1.730 |
| Model group | – | 79.000 ± 22.066 | 6.500 ± 1.314 |
| GNA capsule group | 675 | 163.833 ± 38.879 | 3.000 ± 1.537 |
| SIS capsule group | 250 | 166.667 ± 24.403 | 3.333 ± 0.888 |
| TFR high-dose group | 200 | 160.167 ± 26.219 | 2.000 ± 0.953 |
| TFR mid -dose group | 100 | 151.833 ± 32.755 | 2.667 ± 0.985 |
| TFR low -dose group | 50 | 94.917 ± 7.891 | 4.167 ± 1.642 |
Note: Compared with the model group.
P < 0.05.
P < 0.01.
Effects of TFR on the thymus, spleen, uterine index in the mice perimenopausal model ( ± s, n = 12).
| Group | Dose (mg/kg) | Thymus index (mg/g) | Spleen index (mg/g) | Uterine index (mg/g) |
|---|---|---|---|---|
| Blank group | – | 3.116 ± 0.613 | 6.115 ± 0.904 | 3.116 ± 0.613 |
| Model group | – | 1.685 ± 0.276 | 3.868 ± 0.966 | 1.699 ± 0.525 |
| GNA capsule group | 675 | 2.996 ± 0.092 | 5.851 ± 0.641 | 2.971 ± 0.341 |
| SIS capsule group | 250 | 3.067 ± 0.623 | 5.793 ± 1.114 | 3.073 ± 0.870 |
| TFR high-dose group | 200 | 2.949 ± 0.559 | 5.935 ± 0.959 | 2.946 ± 0.426 |
| TFR mid -dose group | 100 | 2.893 ± 0.111 | 5.791 ± 0.932 | 2.903 ± 0.416 |
| TFR low -dose group | 50 | 1.964 ± 0.547 | 4.563 ± 1.082 | 2.006 ± 0.644 |
Note: Compared with the model group.
* P < 0.05.
P < 0.01.
Effects of TFR on the serum sex hormone level in the mice perimenopausal model ( ± s, n = 12).
| Group | Dose (mg/kg) | E2 (pmol/L) | T (pg/mL) | FSH (U/mL) | LH (U/mL) |
|---|---|---|---|---|---|
| Blank group | – | 30.623 ± 4.055 | 369.548 ± 43.958 | 11.739 ± 5.326 | 1.013 ± 0.300 |
| Model group | – | 20.595 ± 3.567 | 207.167 ± 49.358 | 23.558 ± 4.553 | 2.184 ± 0.361 |
| GNA capsule group | 675 | 28.208 ± 1.965 | 328.833 ± 33.177 | 13.773 ± 4.900 | 1.272 ± 0.332 |
| SIS capsule group | 250 | 28.975 ± 2.692 | 334.310 ± 41.010 | 14.587 ± 3.661 | 1.177 ± 0.220 |
| TFR high-dose group | 200 | 28.017 ± 2.249 | 309.615 ± 73.141 | 13.159 ± 4.847 | 1.204 ± 0.111 |
| TFR mid-dose group | 100 | 27.208 ± 1.205 | 355.000 ± 43.311 | 14.601 ± 4.256 | 1.279 ± 0.117 |
| TFR low-dose group | 50 | 21.097 ± 2.038 | 273.910 ± 32.231 | 17.261 ± 3.676 | 1.666 ± 0.507 |
Note: Compared with the model group.
P < 0.05.
P < 0.01.
Effects of TFR on uterine path morphology in the mice perimenopausal model ( ± s, n = 12).
| Group | Dose (mg/kg) | − | + | ++ | +++ | P |
|---|---|---|---|---|---|---|
| Blank group | – | 11 | 1 | 0 | 0 | |
| Model group | – | 0 | 2 | 4 | 6 | △△ |
| GNA capsule group | 675 | 3 | 5 | 3 | 1 | |
| SIS capsule group | 250 | 3 | 4 | 5 | 0 | |
| TFR high-dose group | 200 | 3 | 4 | 3 | 1 | |
| TFR mid -dose group | 100 | 4 | 6 | 2 | 0 | |
| TFR low -dose group | 50 | 0 | 3 | 6 | 3 |
Note: Compared with the model group.
“−” endometrial epithelial cells, glands, muscle, serous are normal; “+” endometrial epithelial cells, glands small part of atrophy, muscle serous membrane are normal; “++” endometrial epithelial cells, glands partial atrophy, muscle slightly shrinking, serous are normal; “+++” endometrial epithelial cells, glands were obvious atrophy, serous are normal.
P < 0.05.
P < 0.01.
Fig. 1Effect of uterine path morphology on the perimenopausal period in mice (HE × 200).
Effects of TFR on the thymus, spleen path morphology in the mice perimenopausal model ( ± s, n = 12).
| Group | Dose (mg/kg) | Thymic cortex thickness (μm) | Splenic nodule (μm) |
|---|---|---|---|
| Blank group | – | 337.94 ± 26.16 | 427.88 ± 58.96 |
| Model group | – | 215.51 ± 28.11 | 261.52 ± 33.22 |
| GNA capsule group | 675 | 364.53 ± 36.82 | 381.28 ± 59.62 |
| SIS capsule group | 250 | 321.42 ± 66.84 | 340.71 ± 52.41 |
| TFR high-dose group | 200 | 285.96 ± 42.13 | 324.13 ± 35.51 |
| TFR mid-dose group | 100 | 271.46 ± 37.77 | 285.24 ± 25.81 |
| TFR low-dose group | 50 | 279.91 ± 58.15 | 257.07 ± 27.90 |
Note: Compared with the model group.
P < 0.05.
P < 0.01.
Fig. 2Effect of thymus path morphology on the perimenopausal period in mice (HE × 200).
Fig. 3Effect of spleen path morphology on the perimenopausal period in mice (HE × 200).